| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |